Erika Patricia Azorin-Vega

12PUBLICATIONS
22CO-AUTHORS
Pharmaceutical delivery technologiesRadiation therapyBioavailability and ecotoxicologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 15, 2026
[225Ac]Ac-iPSMA Radiopharmaceuticals for Targeted Alpha Therapy: Design, Synthesis, and Preclinical Evaluation.

|Dec 30, 2025
Enhancing Cytosolic Internalization of [177Lu]Lu-iPSMA in Prostate Cancer Cells: The Effect of Conjugating a GRP78 Inhibitor to the Radiotherapeutic Molecule.

Erika Azorín-Vega, Daniel García-Arce, Myrna Luna-Gutiérrez

|Nov 08, 2025
Systematic review and meta-analysis of the efficacy and safety of [177Lu]Lu-edotreotide ([177Lu]Lu-DOTATOC) for the treatment of neuroendocrine tumors.

Richard P Baum, Julia G Fricke, Tristan Ruhwedel

|Jul 30, 2025
Synthesis and Evaluation of [18F]AlF-NOTA-iPD-L1 as a Potential Theranostic Pair for [177Lu]Lu-DOTA-iPD-L1.

Guillermina Ferro-Flores, Myrna Luna-Gutiérrez, Blanca Ocampo-García

|Jul 29, 2025
Effects of Targeted Radionuclide Therapy on Cancer Cells Beyond the Ablative Radiation Dose.

Guillermina Ferro-Flores, Erika Azorín-Vega, Blanca Ocampo-García

|Nov 27, 2024
Theranostic Potential of the iPSMA-Bombesin Radioligand in Patients with Metastatic Prostate Cancer: A Pilot Study.

Sofía González-Rueda, Osvaldo García-Pérez, Myrna Luna-Gutiérrez

Pageof 2

Frequent Collaborators

11 joint publications

Guillermina Ferro-Flores

10 joint publications

Blanca Ocampo-García

9 joint publications

Myrna Luna-Gutiérrez

7 joint publications

Clara Santos-Cuevas